6
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Chemical Faecal Fat Using Single Stools

, , &
Pages 277-280 | Received 24 Nov 1970, Accepted 10 Dec 1970, Published online: 25 Feb 2010

REFERENCES

  • Annegers, J. H., Boutwell, J. H. & Ivy, A. C. 1948. The effect of dietary fat on faecal fat excretion and subjective symptoms in man. Gastroenterology 10, 486–495.
  • Black, D. A. K., Bound, J. P. & Fourman, L. P. R. 1947. Fat absorption in tropical sprue. Quart. J. Med. 16, 99–109.
  • Davignon, Jean, Simmonds, W. J. & Ahrens, E. H., Jr. 1968. Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic-function. J. clin. Invest. 47, 127–138.
  • Fourman, C. P. R., Higgins, G., Quelch, P., O'Brien, J. R. P. & Witts, L. J. 1948. The investigation and diagnosis of steatorrhoea. Clin. Sci. 7, 121–134.
  • Frazer, A. C. 1960. Daily fatty acid excretion Association of Clinical Pathologists, Broadsheet no. 28.
  • Gabriel, J. B., Solomon, N. A., Fierst, S. M. & Sass, M. 1963. Evaluation of chromic oxide marker in the absorption of fat. Amer. J. dig. Dis. 8, 280–291.
  • Irwin, M. I., & Crampton, E. W. 1951. The use of chromic oxide as an index material in digestion trials with human subjects. J. Nutr. 43, 77–85.
  • Lee, M. F., Temperley, J. M. & Dick, M. 1969. Estimation of faecal fat excretion using cuprous thiocyanate as a continuous marker. Gut 10, 754–759.
  • Rose, G. A. 1964. Experiences with the use of interrupted carmine red and continuous chromium sesquioxide marking of human faeces with reference to calcium, phosphorus, and magnesium. Gut 5, 274–279.
  • Senior, J. R. 1968. Steatorrhea and the measurement of fecal fat. Gastroenterology 55, 310–311.
  • Stanley, M. M. & Cheng, S. H. 1956. Cholesterol exchange in the gastrointestinal tract in normal and abnormal subjects. Gastroenterology 30, 62–74.
  • Whitby, L. G. & Lang, Daphne. 1960. Experience with the chromic oxide method of fecal marking in metabolic balance investigations on humans. J. clin. Invest. 39, 854–863.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.